ContraFect to Present New Data Demonstrating the Potential Efficacy of Its Engineered Lysins Against Antibiotic-Resistant Pathogens at ASM Microbe 2023
Stock Information for Broadwind Inc.
Loading
Please wait while we load your information from QuoteMedia.